GYRE THERAPEUTICS INC. - COMMON STOCK
9.9900
10-January-25 16:45:00
15 minutes delayed
Stocks
+0.3700
+3.85%
Today's range
9.8000 - 10.5800
ISIN
N/A
Source
NASDAQ
-
Gyre Therapeutics Announces the Appointment of Ping Zhang to Board of Directors
06 Jan 2025 07:00:00 By Nasdaq GlobeNewswire
-
13 Nov 2024 06:00:00 By Nasdaq GlobeNewswire
-
22 Oct 2024 16:05:00 By Nasdaq GlobeNewswire
-
Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference
01 Oct 2024 16:05:00 By Nasdaq GlobeNewswire
-
Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
04 Sep 2024 16:05:00 By Nasdaq GlobeNewswire
-
13 Aug 2024 06:00:00 By Nasdaq GlobeNewswire
-
Gyre Therapeutics to Present at Sidoti Virtual Investor Conference
09 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors
08 Aug 2024 16:05:00 By Nasdaq GlobeNewswire
-
02 Jul 2024 16:05:00 By Nasdaq GlobeNewswire
-
Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology
18 Jun 2024 16:05:00 By Nasdaq GlobeNewswire
-
30 May 2024 16:05:00 By Nasdaq GlobeNewswire
-
Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes
28 May 2024 16:05:00 By Nasdaq GlobeNewswire
-
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
09 May 2024 16:10:00 By Nasdaq GlobeNewswire
-
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
26 Mar 2024 06:00:00 By Nasdaq GlobeNewswire
-
Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
21 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
13 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >